Preimplantation Genetic Testing Companies

Illumina a leader in NGS technology, launched two new NGS-based test kits specifically designed for PGT-A (aneuploidy) analysis. These kits offer improved accuracy and faster turnaround times, potentially making PGT more accessible to a wider range of patients.

The Cooper Companies, released PGT-Complete, a comprehensive PGT-A testing platform that includes additional analyses like Parental QC, Genetic PN check, and Origin of Aneuploidy. This platform provides more detailed information about embryos, potentially improving selection for implantation

Vitrolife, a Swedish company specializing in reproductive technologies, acquired Igenomix, a Spanish leader in reproductive genetic testing services. This acquisition strengthens Vitrolife's position in the PGT market and expands its geographical reach.

Orchid Health U.S. company, announced plans to offer whole-genome sequencing (WGS) of embryos to fertility clinics and their patients. This controversial move raises ethical concerns and regulatory hurdles, but it also has the potential to provide even more comprehensive information about embryos.

• Natera, Inc.


• CooperSurgical, Inc.


• Hoffmann-La Roche AG


• Illumina, Inc.


• IGENOMIX


• Reprogenetics, LLC


• Genea Limited


• PerkinElmer, Inc.


• Genesis Genetics Ltd.


• Quest Diagnostics Incorporated


• Thermo Fisher Scientific, Inc


• Bioarrayn Genetics


• Laboratory Corporation of America Holdings


• California Pacific Medical Center


• Reproductive Health Science Ltd